Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    Fenofibrate May Protect Diabetics Against Loss of Renal Function: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Diabetes 11/03/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
      Diabetes Management - Pearls of Lipid Control
      Obesity Management in Patients with Type 2 Diabetes

      Webcasts/CME archive

       Recent cases - Diabetes
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Compound Heterozygous Mutation of Aquaporin 2 Gene in Woman Patient with Congenital Nephrogenic Diabetes Insipidus

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Dual Wave Insulin Bolus Administration Most Effective In Comparison Of Four Methods

        A DGReview of :"Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes"
        Diabetic Medicine

        05/06/2002
        By James Adams


        A dual wave of insulin administration proved the most effective method for managing glucose levels following a meal high in carbohydrates, calories and fat.

        Investigators from the Department of Paediatrics at the University of Colorado Health Sciences Center in Denver, Colorado, United States, compared four methods of short-acting insulin bolus administration.

        Nine subjects receiving continuous subcutaneous insulin infusion using insulin lispro (Humalog®) consumed the same meal on four occasions separated by one week.

        At the time of meal consumption, the effectiveness of one of four methods of insulin administration was tested. The four methods were (1) single bolus, (2) two separate boluses, (3) the entire bolus administered as a square wave over two hours or (4) a dual wave consisting of 70 percent given as a bolus and 30 percent delivered as a square wave over two hours. In all cases, administration began 10 minutes before the meal and the final dosage of insulin was the same.

        The lowest changes in blood glucose values from fasting to 90 and 120 minutes were achieved with the dual wave administration.

        Glucose levels were significantly lower after four hours in both the dual and square-wave method compared with single or double bolus administration.
        Diabet Med 2002; 19(4): 317-321. "Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send